当前位置:首页 - 行情中心 - 迪哲医药-U(688192) - 财务分析

迪哲医药-U

(688192)

  

流通市值:254.31亿  总市值:256.49亿
流通股本:4.61亿   总股本:4.65亿

迪哲医药-U(688192)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润-0.97亿元,每股收益-0.21元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益123518.08万元,未分配利润-421912.80万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产301301.97万元,负债177783.89万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入252,521,933.82801,135,558.29586,301,134.9355,001,420.82
营业总成本365,009,076.261,654,178,465.581,234,483,936.24779,607,061.37
其他经营收益
营业利润-96,366,424.2-766,362,723.31-582,901,080.21-378,990,328
利润总额-96,342,303.81-767,126,713.42-582,901,080.21-378,990,328
净利润-96,702,205.01-768,517,444.68-582,953,152.35-379,042,400.14
每股收益
其他综合收益----
综合收益总额-96,702,205.01-768,517,444.68-582,953,152.35-379,042,400.14
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计2,206,328,946.162,182,677,146.712,127,206,220.472,404,927,026.78
非流动资产:
非流动资产合计806,690,760.82819,852,041.7828,140,402.04813,533,558.53
资产总计3,013,019,706.983,002,529,188.412,955,346,622.513,218,460,585.31
流动负债:
流动负债合计782,358,538.05985,234,095.28861,920,670.5888,200,263.76
非流动负债:
非流动负债合计995,480,353.85721,604,244.62649,692,509.71701,482,796.21
负债合计1,777,838,891.91,706,838,339.91,511,613,180.211,589,683,059.97
所有者权益(或股东权益):
归属于母公司股东权益合计1,234,492,519.321,293,857,703.251,440,437,716.451,624,158,702.71
股东权益合计1,235,180,815.081,295,690,848.511,443,733,442.31,628,777,525.34
负债和股东权益合计3,013,019,706.983,002,529,188.412,955,346,622.513,218,460,585.31
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计269,066,184.94846,127,427.66595,116,720.01382,022,208.42
经营活动现金流出小计469,543,816.091,434,452,216.231,019,173,567.99646,691,577.16
经营活动产生的现金流量净额-200,477,631.15-588,324,788.57-424,056,847.98-264,669,368.74
投资活动产生的现金流量:
投资活动现金流入小计1,896,479,023.29,968,760,226.687,282,910,041.683,631,604,581.35
投资活动现金流出小计1,989,913,521.1411,167,469,026.067,734,943,303.924,148,832,364.76
投资活动产生的现金流量净额-93,434,497.94-1,198,708,799.38-452,033,262.24-517,227,783.41
筹资活动产生的现金流量:
筹资活动现金流入小计425,308,080.532,604,143,496.052,333,585,746.052,333,585,746.05
筹资活动现金流出小计198,961,877.8775,458,604.24692,677,328.45557,210,081.7
筹资活动产生的现金流量净额226,346,202.731,828,684,891.811,640,908,417.61,776,375,664.35
汇率变动对现金及现金等价物的影响-158,619.01-394,408.41-223,484.38-77,388.63
现金及现金等价物净增加额-67,724,545.3741,256,895.45764,594,823994,401,123.57
期末现金及现金等价物余额223,422,092.71291,146,638.081,014,484,565.631,244,290,866.2
补充资料:
现金及现金等价物的净增加额-41,256,895.45-994,401,123.57
最新报告期:2026-05-12
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
兴业证券孙媛媛,杨希成,黄翰漾-1.10-0.381.332026-05-12
天风证券杨松,曹文清-0.910.151.052026-05-11
东吴证券朱国广-1.040.141.132026-05-08
中金公司张琎,刘雅馨,朱言音-0.710.53--2026-05-03
东海证券杜永宏-0.960.171.032026-04-17
TOP↑